Find information on thousands of medical conditions and prescription drugs.

Zoladex

Goserelin is an injectable gonadotropin releasing hormone agonist (GnRH agonist). It stops the production of sex hormones (testosterone and oestrogen) and is used to treat hormone-sensitive cancers of the prostate and breast (in pre-/perimenopausal women) and some benign gynaecological disorders (endometriosis, uterine fibroids and endometrial thinning). In addition, goserelin is used in assisted reproduction. more...

Home
Diseases
Medicines
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Zafirlukast
Zagam
Zalcitabine
Zaleplon
Zanaflex
Zanamivir
Zantac
Zarontin
Zelnorm
Zerit
Zestoretic
Zestril
Zetia
Zevalin
Ziagen
Zidovudine
Zileuton
Ziprasidone
Zithromax
Zocor
Zofran
Zoladex
Zoledronic acid
Zolmitriptan
Zoloft
Zolpidem
Zometa
Zomig
Zonegran
Zonisamide
Zopiclone
Zosyn
Zovia
Zovirax
Zyban
Zymar
Zyprexa
Zyrtec
Zyvox

It is available as a 1-month depot and a long-acting 3-month depot. Both depots are used for the treatment of prostate cancer, endometriosis and uterine fibroids but only the 1-month depot is approved for breast cancer, endometrial thinning and assisted reproduction.

Goserelin is marketed by AstraZeneca with the brand name Zoladex. It was first launched in 1987 and is currently the second-largest selling LHRHa in the world. It is currently available in more than one hundred markets.

Read more at Wikipedia.org


[List your site here Free!]


Current Therapy for Prostate Cancer: Focus on Goserelin : Proceedings of the Zoladex International Symposium September 20-21, 1991, Kobe, Japan (Cur) $304.89

Zoladex Before Ablation Leads to Better Outcomes
ORLANDO, FLA. -- Pretreatment with goserelin acetate improves long-term outcomes in patients undergoing endometrial ablation for dysfunctional uterine ...
The truth about fibroids: our guide to the latest in treatment - health
Kimberly Reid had always had fairly regular periods. But over the course of a year and a half, the 34-year-old realized her four-to-five-day periods ...
Mitozantrone-induced onycholysis associated with subungual abscesses, paronychia, and pyogenic granuloma
Abstract Chemotherapeutic agents may induce a wide variety of adverse mucocutaneous effects, including nail changes. We present a case of atypical ...
Pharmaco-fakery
We've been hearing a lot about counterfeit drugs this month, from thought-provoking sessions at the American Association of Pharmaceutical Scientists' ...
Zoladex marketing nets $355 million fine
WILMINGTON, Del. -- AstraZeneca Pharmaceuticals pleaded guilty Friday to violating a federal drug marketing law and will pay $355 million to settle ...
Why get a second pathology opinion for breast cancer: an interview
Of all the tests given to a woman newly diagnosed with breast cancer, one is crucial in determining her treatment plan. It measures the tumor's "hormone ...
Research and Markets: the Endometriosis Market is Expected to Change Dramatically Following the Patent Expiry of Key Brands Lupron Depot, Zoladex and Suprefact
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com) has announced the addition of Pipeline Insight: Endometriosis - Growing the Patient Population is Key to Unlocking the Ma
AstraZeneca to pay $355 million fine - Updates
AstraZeneca Pharmaceuticals LP of Wilmington, Del., has agreed to pay a $355 million fine to resolve criminal charges and civil liabilities stemming ...

Home Contact Resources Exchange Links ebay